Use of triacontanol in preparation of medicaments for...

Details Use of triacontanol in preparation of medicaments for... Use of triacontanol in preparation of medicaments for...

2011-01-04

2011-01-04

Witherspoon, Sikarl A (Department: 1621)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

C-o-group doai

Reexamination Certificate

active

07863337

ABSTRACT:
Use of triacontanol in preparation of human medicaments for treatment of cancers, especially liver cancer, intestinal cancer, and lung cancer. Triacontanol can be formulated into many formulations, such as oral tablets, capsules, drop pills, sustained-released formulation, injectable solution, injectable powder, suspension, and emulsion.

REFERENCES:
patent: 5283328 (1994-02-01), Kovacs et al.
patent: 5856316 (1999-01-01), Laguna Granja et al.
patent: 6596776 (2003-07-01), Gamble et al.
patent: 2006/0020045 (2006-01-01), Berlin
patent: 2006/0057237 (2006-03-01), Darro et al.

Affiliated with

Also associated with

Rating

Use of triacontanol in preparation of medicaments for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of triacontanol in preparation of medicaments for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of triacontanol in preparation of medicaments for... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2736957